These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1570 related items for PubMed ID: 15478324
1. Comparative value of BNP and NT-proBNP in diagnosis of heart failure. Fonseca C, Sarmento PM, Minez A, Gonçalves E, Covas R, Dias AR, Pina MJ, Ceia F. Rev Port Cardiol; 2004; 23(7-8):979-91. PubMed ID: 15478324 [Abstract] [Full Text] [Related]
2. [Personal experience with determination of NT-proBNP in clinical practice]. Stejskal D, Oral I, Lacnák B, Juráková R, Horalík D, Adamovská S, Prosková J, Hrabovská I, Ozanová G. Vnitr Lek; 2003 Feb; 49(2):121-6. PubMed ID: 12728579 [Abstract] [Full Text] [Related]
10. Plasma amino-terminal pro-brain natriuretic peptide: a novel approach to the diagnosis of cardiac dysfunction. Campbell DJ, Mitchelhill KI, Schlicht SM, Booth RJ. J Card Fail; 2000 Jun; 6(2):130-9. PubMed ID: 10908087 [Abstract] [Full Text] [Related]
11. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure. Rothenburger M, Wichter T, Schmid C, Stypmann J, Tjan TD, Berendes E, Etz C, Pioux A, Löher A, Wenzelburger F, Drees G, Hoffmeier A, Breithardt G, Scheld HH. J Heart Lung Transplant; 2004 Oct; 23(10):1189-97. PubMed ID: 15477114 [Abstract] [Full Text] [Related]
13. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure. Koç M, Bozkurt A, Yildiray-Sahin D, Unal I, Acartürk E. Cardiol J; 2009 Oct; 16(1):43-9. PubMed ID: 19130415 [Abstract] [Full Text] [Related]
15. NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies. McDonagh TA, Holmer S, Raymond I, Luchner A, Hildebrant P, Dargie HJ. Eur J Heart Fail; 2004 Mar 15; 6(3):269-73. PubMed ID: 14987575 [Abstract] [Full Text] [Related]
18. Neurohormonal activation and diagnostic value of cardiac peptides in patients with suspected mild heart failure. Mikkelsen KV, Bie P, Møller JE, Videbaek L, Villadsen HD, Haghfelt T. Int J Cardiol; 2006 Jun 28; 110(3):324-33. PubMed ID: 16213609 [Abstract] [Full Text] [Related]
19. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD. J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563 [Abstract] [Full Text] [Related]
20. Amino-terminal pro-B-type natriuretic peptide testing for the diagnosis or exclusion of heart failure in patients with acute symptoms. Januzzi JL, Chen-Tournoux AA, Moe G. Am J Cardiol; 2008 Feb 04; 101(3A):29-38. PubMed ID: 18243855 [Abstract] [Full Text] [Related] Page: [Next] [New Search]